Patients with systemic sclerosis have a better prognosis now than they did 30 years ago, and the frequency of renal-crisis-related death has decreased markedly. As a result, there is an increasing burden of cardiovascular disease in these patients. In this article, the authors describe the techniques that can be used to assess vascular damage, and outline the requirements of future research in this area.
